Carlsmed Reports 86% Revenue Growth for Full Year 2025

Reuters
01/12
Carlsmed Reports 86% Revenue Growth for Full Year 2025

Carlsmed Inc. announced preliminary and unaudited revenue results for the fourth quarter and full year ended December 31, 2025. The company reported fourth quarter 2025 revenue of approximately $15.2 million, representing a 61% increase compared to the fourth quarter of 2024. Full year 2025 revenue was approximately $50.5 million, an 86% increase over the full year 2024. The company also noted the addition of 101 new surgeon users in 2025, marking a 61% increase in its total surgeon user base compared to the prior year. These preliminary results are subject to revision until the company files its full financial results for 2025 in its Annual Report on Form 10-K.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Carlsmed Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9623457-en) on January 12, 2026, and is solely responsible for the information contained therein.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10